IXHL Company Profile and Key Details

Q: Who are the executives of IXHL?

Dr. Mark BleackleyChief Scientific Officer, Head of Programs & Member of the Advisory BoardMr. John Michailidis B.Sc., EMBA, M.A.I.C.D.Chief Executive Officer of IncannexTMMr. Lekhram Changoer M.Sc.Chief Technical OfficerMr. Joseph SwanHead of Fin.Mr. Joel Bradley LathamMD, Chief Executive Officer & Executive DirectorMs. Rosemarie WalshVice President of Clinical Operations & Member of the Advisory Board

NASDAQ : IXHL

Incannex Healthcare

$3.25

-0.005-0.15%

At Close 4:00 PM

60.17

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Incannex Healthcare Limited (IXHL) stock declined over -0.15%, trading at $3.25 on NASDAQ, down from the previous close of $3.25. The stock opened at $3.25, fluctuating between $3.22 and $3.31 in the recent session.

Stock Snapshot

3.25

Prev. Close

38.82M

Market Cap

3.22

Day Low

-4.74

P/E Ratio

-0.685

EPS (TTM)

-0.02

Cash Flow per Share

3.25

Open

11.96M

Number of Shares

3.31

Day High

78.06%

Free Float in %

1.19

Book Value

45.62K

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Sep 04, 2026	3.22	3.31	3.22	3.25	45.62K
Sep 03, 2026	3.27	3.29	3.13	3.25	77.2K
Sep 02, 2026	3.20	3.33	3.19	3.27	34.1K
Sep 01, 2026	3.35	3.40	3.17	3.18	156.98K
Aug 31, 2026	3.58	3.62	3.35	3.35	79.55K
Aug 28, 2026	3.70	3.79	3.58	3.64	42.73K
Aug 27, 2026	3.71	3.76	3.65	3.69	60.57K
Aug 26, 2026	3.71	3.85	3.69	3.70	87.78K
Aug 25, 2026	3.61	3.94	3.61	3.75	201.11K
Aug 24, 2026	3.51	3.66	3.41	3.62	60.75K
Aug 21, 2026	3.62	3.65	3.51	3.57	70.2K
Aug 20, 2026	3.38	3.62	3.35	3.62	75.79K
Aug 19, 2026	3.35	3.47	3.30	3.44	99.55K
Aug 18, 2026	3.31	3.44	3.25	3.36	101.76K
Aug 17, 2026	3.30	3.38	3.24	3.32	78.38K
Aug 14, 2026	3.18	3.29	3.16	3.28	100.29K
Aug 13, 2026	3.20	3.23	3.13	3.16	72.43K
Aug 12, 2026	3.16	3.22	3.09	3.17	74.35K
Aug 11, 2026	3.30	3.30	3.14	3.20	100.52K
Aug 10, 2026	3.12	3.25	3.12	3.23	84.25K

Contact Details

Sydney, NSW 2153

Australia

https://www.incannex.com 614 257 03805

About Company

Incannex Healthcare Limited is an Australian company dedicated to the research, development, and commercialization of medicinal cannabinoid products. The firm offers pharmaceutical-grade cannabinoid compounds under its proprietary Incannex brand. Its product pipeline includes several key assets: IHL-42X: This compound is currently undergoing Phase II clinical evaluation for the treatment of obstructive sleep apnea (OSA). Incannex partners with The Alfred Hospital and Novotech on this specific clinical program. IHL-216A: Designed to address traumatic brain injury (TBI). Furthermore, the Monash Trauma Group, part of Monash University's Department of Neuroscience, is conducting a study on IHL-216A's protective effects against sports-related concussions. IHL-675A: A unique formulation combining hydroxychloroquine and cannabidiol, developed for both the prevention and management of a range of inflammatory conditions. These include acute respiratory distress syndrome (ARDS), chronic obstructive pulmonary disease (COPD), asthma, bronchitis, rheumatoid arthritis, and inflammatory bowel diseases. Originally established in 2001 as Impression Healthcare Limited, the company officially changed its name to Incannex Healthcare Limited in June 2020. Incannex maintains its corporate headquarters in Sydney, Australia.

Stock Peers

ARGX

-20.31-1.93%

argenx SE$1,033.15 REGN

-15.75-1.87%

Regeneron Pharmaceuticals, Inc.$827.72 VRTX

-11.84-2.12%

Vertex Pharmaceuticals Incorporated$546.12 MDGL

-1.53-0.28%

Madrigal Pharmaceuticals, Inc.$541.08 UTHR

-2.63-0.54%

United Therapeutics Corporation$487.61 ONC

-4.42-1.22%

BeOne Medicines AG$358.26 KRYS

-13.23-3.56%

Krystal Biotech, Inc.$358.24 PRAX

-3.34-0.94%

Praxis Precision Medicines, Inc.$351.81 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-4.14-1.43%

Ligand Pharmaceuticals Incorporated$285.60

Frequently Asked Questions

What is the current Incannex Healthcare Limited (IXHL) stock price?

Incannex Healthcare Limited (NASDAQ: IXHL) stock price is $3.25 in the last trading session. During the trading session, IXHL stock reached the peak price of $3.31 while $3.22 was the lowest point it dropped to. The percentage change in IXHL stock occurred in the recent session was -0.15% while the dollar amount for the price change in IXHL stock was - $0.01.

IXHL's industry and sector of operation?

The NASDAQ listed IXHL is part of Biotechnology industry that operates in the broader Healthcare sector. Incannex Healthcare Limited designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of IXHL?

Dr. Mark Bleackley
Chief Scientific Officer, Head of Programs & Member of the Advisory Board
Mr. John Michailidis B.Sc., EMBA, M.A.I.C.D.
Chief Executive Officer of IncannexTM
Mr. Lekhram Changoer M.Sc.
Chief Technical Officer
Mr. Joseph Swan
Head of Fin.
Mr. Joel Bradley Latham
MD, Chief Executive Officer & Executive Director
Ms. Rosemarie Walsh
Vice President of Clinical Operations & Member of the Advisory Board

How IXHL did perform over past 52-week?

IXHL's closing price is 30.32% higher than its 52-week low of $2.49 where as its distance from 52-week high of $20.31 is -84.02%.

How many employees does IXHL have?

Number of IXHL employees currently stands at 12.

Link for IXHL official website?

Official Website of IXHL is: https://www.incannex.com

How do I contact IXHL?

IXHL could be contacted at phone 614 257 03805 and can also be accessed through its website. IXHL operates from 207/11 Solent Circuit, Sydney, NSW 2153, Australia.

How many shares of IXHL are traded daily?

IXHL stock volume for the day was 45.62K shares. The average number of IXHL shares traded daily for last 3 months was 189.68K.

What is the market cap of IXHL currently?

The market value of IXHL currently stands at $38.82M with its latest stock price at $3.25 and 11.96M of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	12
Beta	2.75
Sales or Revenue	$86.00K
5Y Sales Change%	0.027%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

Employees	12
Beta	2.75
Sales or Revenue	$86.00K
5Y Sales Change%	0.027%
Fiscal Year Ends	June
Sector	Healthcare
Industry	Biotechnology

IXHL Company Profile and Key Details

Incannex Healthcare

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Technical Performance

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Shareholding & Insider Activity

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Technical Performance

Dividend & Fair Value

Financial & Profitability Overview

Quarterly Financial Highlights

Earnings & Analyst Outlook

Shareholding & Insider Activity

Company Overview

Valuation Metrics

Price Forecast & Outlook

Key Takeaways